HER3 has little intrinsic tyrosine kinase activity, but data suggest it frequently forms heterodimers with other receptor tyrosine kinases that can activate oncogenic signaling via the PI3K/Akt pathway and Src kinase, enhancing tumor cell survival, proliferation, and progression. Here, ERBB3 is linked to neoplasm.